bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.060
+0.020 (1.92%)
At close: Mar 9, 2026, 4:00 PM EDT
1.080
+0.020 (1.89%)
After-hours: Mar 9, 2026, 7:59 PM EDT
bioAffinity Technologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 6.78 | 9.36 | 2.53 | 0 | - | - |
| Revenue Growth (YoY) | -27.66% | 269.68% | 52627.44% | - | - | - |
| Cost of Revenue | 4.89 | 5.98 | 1.74 | 0 | - | - |
| Gross Profit | 1.89 | 3.38 | 0.79 | 0 | - | - |
| Selling, General & Admin | 9.8 | 9.94 | 6.79 | 2.48 | 1.07 | 0.99 |
| Research & Development | 1.94 | 1.78 | 1.72 | 1.52 | 1.14 | 1.61 |
| Operating Expenses | 12.27 | 12.33 | 8.76 | 4.02 | 2.21 | 2.6 |
| Operating Income | -10.38 | -8.95 | -7.97 | -4.01 | -2.21 | -2.6 |
| Interest Expense | -0.06 | -0.09 | -0.04 | -2.53 | -1 | -0.38 |
| Interest & Investment Income | 0.01 | 0.02 | 0.12 | 0.05 | 0 | 0 |
| Other Non Operating Income (Expenses) | -4.27 | 0 | -0.03 | -1.87 | -3.36 | - |
| EBT Excluding Unusual Items | -14.7 | -9.03 | -7.92 | -8.36 | -6.56 | -2.99 |
| Other Unusual Items | - | - | - | 0.21 | 0.24 | -4.28 |
| Pretax Income | -14.7 | -9.03 | -7.92 | -8.15 | -6.32 | -7.27 |
| Income Tax Expense | 0.04 | 0.01 | 0.02 | 0 | 0 | 0 |
| Net Income | -14.74 | -9.04 | -7.94 | -8.15 | -6.33 | -7.27 |
| Net Income to Common | -14.74 | -9.04 | -7.94 | -8.15 | -6.33 | -7.27 |
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | 0 |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | 0 |
| Shares Change (YoY) | 102.65% | 38.61% | 94.43% | 68.17% | 0.02% | - |
| EPS (Basic) | -20.28 | -22.37 | -27.22 | -54.37 | -70.94 | -81.52 |
| EPS (Diluted) | -20.28 | -22.37 | -27.22 | -54.37 | -70.94 | -81.52 |
| Free Cash Flow | -8.51 | -7.34 | -6.06 | -4.29 | -2.05 | -2.21 |
| Free Cash Flow Per Share | -11.71 | -18.17 | -20.79 | -28.61 | -22.98 | -24.79 |
| Gross Margin | 27.86% | 36.09% | 31.26% | 90.28% | - | - |
| Operating Margin | -153.20% | -95.64% | -314.84% | -83511.51% | - | - |
| Profit Margin | -217.50% | -96.56% | -313.41% | -169771.25% | - | - |
| Free Cash Flow Margin | -125.53% | -78.44% | -239.32% | -89336.50% | - | - |
| EBITDA | -9.85 | -8.35 | -7.72 | -4 | -2.2 | -2.58 |
| EBITDA Margin | -145.31% | -89.17% | - | - | - | - |
| D&A For EBITDA | 0.53 | 0.61 | 0.25 | 0.01 | 0 | 0.02 |
| EBIT | -10.38 | -8.95 | -7.97 | -4.01 | -2.21 | -2.6 |
| EBIT Margin | -153.20% | -95.64% | - | - | - | - |
| Advertising Expenses | - | 0.27 | 0.09 | 0.04 | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.